Arkolith/Insider Trading/FREQ/Form 4

Loose Christopher R.

Chief Scientific OfficerFrequency Therapeutics, Inc. (FREQ) · full profile →Form 4 · filed Jul 11, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$953
Net Open-Market Flow
-$953
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 10, 2023Sell(S)1K$0.37$48266K
Jul 10, 2023Option exercise(M)5K——71K
Jul 7, 2023Sell(S)1K$0.36$47063K
Jul 7, 2023Option exercise(M)5K——67K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 10, 2023Option exercise(M)5K——132K
Jul 7, 2023Option exercise(M)5K——136K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001127602-23-020573) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML